Luteolin as an adjuvant effectively enhanced the efficacy of adoptive tumor-specific CTLs therapy. Lai Z, Pang Y, Zhou Y, Chen L, et al. BMC Cancer 2025;25:411.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lai Z, Pang Y, Zhou Y, Chen L, et al. Luteolin as an adjuvant effectively enhanced the efficacy of adoptive tumor-specific CTLs therapy. BMC Cancer 2025;25:411.
PMID: 40050776